Jefferies Financial Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Jefferies Financial Group’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-71,992	Closed	-$907K	–	1715
2025 Q4	$907K	Buy	+71,992	New	+$824K	﹤0.01%	1131
2024 Q4	–	Sell	-80,000	Closed	-$666K	–	1574
2024 Q3	$666K	Sell	80,000 -115,008	-59%	-$899K	﹤0.01%	903
2024 Q2	$1.24M	Buy	+195,008	New	+$1.24M	0.01%	680

Other funds holding AMRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Jefferies Financial Group's AMRX Position: Q1 2026 in Review

Jefferies Financial Group sold out of Amneal Pharmaceuticals (AMRX) in Q1 2026, closing a stake of 71,992 shares — an estimated $907K sold.

Jefferies Financial Group first reported a position in AMRX in Q2 2024 and held it in 3 quarters. The position peaked at $1.24M in Q2 2024. 315 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

Jefferies Financial Group reported no remaining Amneal Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Jefferies Financial Group sold 71,992 Amneal Pharmaceuticals shares in Q1 2026, an estimated $907K.
Jefferies Financial Group first reported a position in Amneal Pharmaceuticals in Q2 2024 and held it in 3 quarters.
Jefferies Financial Group's Amneal Pharmaceuticals position peaked at $1.24M in Q2 2024.
315 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.